Skip to main content

Baird Melissa's Form 4 filing

Hims & Hers Health, Inc. (HIMS) · filed May 11, 2023

Accession no.
0001773751-23-000131
Filed
May 11, 2023, 2:04 PM ET
Trade date
May 9-10, 2023
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $139.8K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Baird MelissaCIK 0001837815Officer (Chief Operating Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 9, 2023Class A Common StockMOption exerciseAcquired+12,966$0.40+$5,186.4435,545Direct
May 9, 2023Class A Common StockSSaleDisposed−3,833$10.78F3−$41,310.16431,712Direct
May 9, 2023Class A Common StockSSaleDisposed−9,133$10.78F4−$98,496.67422,579Direct
May 10, 2023Class A Common StockMOption exerciseAcquired+12,966$0.40+$5,186.4435,545Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 9, 2023Class A Common StockMOption exerciseDisposed−12,966$0.40−$5,186.4893,666Direct
May 10, 2023Class A Common StockMOption exerciseDisposed−12,966$0.40−$5,186.4880,700Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $10.51 - $11.48. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $10.52 - $11.425. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)